Published in J Biol Chem on May 15, 2003
CD14 modulates inflammation-driven insulin resistance. Diabetes (2011) 1.11
Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun (2005) 0.95
Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun (2012) 0.88
The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection. Clin Exp Immunol (2011) 0.88
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immun (2008) 0.88
Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol (2004) 0.84
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res (2010) 0.82
LPS-binding protein enables intestinal epithelial restitution despite LPS exposure. J Pediatr Gastroenterol Nutr (2012) 0.82
Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study. BMC Med Genomics (2011) 0.81
Endotoxemia-menace, marker, or mistake? J Leukoc Biol (2016) 0.80
The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis. J Lipid Res (2014) 0.80
Postnatal development of hepatic innate immune response. Inflammation (2011) 0.78
Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol Syst Biol (2016) 0.78
Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest (2005) 3.91
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem (2002) 2.66
Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res (2004) 2.52
Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity (2006) 2.51
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol (2005) 2.41
TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol (2007) 2.32
Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives. Genome Res (2009) 2.10
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med (2008) 1.84
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res (2005) 1.77
Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res (2008) 1.75
Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res (2008) 1.58
Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun (2005) 1.53
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon control. Genome Res (2010) 1.46
Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J Endotoxin Res (2003) 1.31
Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res (2006) 1.30
Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J (2004) 1.30
Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol (2006) 1.25
Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun (2006) 1.24
TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol (2004) 1.23
Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol (2002) 1.20
Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death. J Exp Med (2003) 1.11
Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine (2006) 1.07
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J (2006) 1.03
Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J Biol Chem (2003) 1.03
Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med (2003) 0.99
Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein. Biochem J (2005) 0.98
MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. Arterioscler Thromb Vasc Biol (2011) 0.98
Arenimycin, an antibiotic effective against rifampin- and methicillin-resistant Staphylococcus aureus from the marine actinomycete Salinispora arenicola. J Antibiot (Tokyo) (2009) 0.95
Epithelial p38alpha controls immune cell recruitment in the colonic mucosa. PLoS Pathog (2010) 0.95
Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Biochem Biophys Res Commun (2005) 0.93
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med (2002) 0.91
The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol Med Microbiol (2003) 0.89
Characterization of monoclonal antibodies to human soluble MD-2 protein. Hybridoma (Larchmt) (2006) 0.88
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immun (2008) 0.88
Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists. J Lipid Res (2012) 0.87
TLR2 is required for the altered transcription of p75NGF receptors in gram positive infection. Neurochem Res (2006) 0.87
The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immun (2012) 0.86
The role of reactive oxygen intermediates in experimental coccidioidomycois in mice. BMC Microbiol (2011) 0.84
Mutational analysis of membrane and soluble forms of human MD-2. J Biol Chem (2006) 0.83
Factors regulated by interferon gamma and hypoxia-inducible factor 1A contribute to responses that protect mice from Coccidioides immitis infection. BMC Microbiol (2012) 0.83
Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol (2006) 0.82
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res (2010) 0.82
Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology (2011) 0.81
Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors. Mol Pharmacol (2007) 0.81
The use of small molecule probes to study spatially separated stimulus-induced signaling pathways. Bioorg Med Chem Lett (2012) 0.77
Gene expression in human fungal pathogen Coccidioides immitis changes as arthroconidia differentiate into spherules and mature. BMC Microbiol (2013) 0.75